How to buy GlaxoSmithKline shares | 1664.8p

Own GlaxoSmithKline shares in just a few minutes.

Fact checked
Picture not described

The global stock market has taken a big hit recently due to the ongoing coronavirus pandemic. While the GSK share price has also dropped, investors may see it GlaxoSmithKline shares as a safer long-term bet, especially given its history with developing vaccines. GlaxoSmithKline plc (LON:GSK) is a British pharmaceutical company based in Brentford. It is part of the FTSE 100 and helped developed the world’s first malaria vaccine in 2014.

How to buy shares in GlaxoSmithKline

  1. Choose a share-dealing platform. If you’re a beginner, our table below can help you choose.
  2. Open your account. You’ll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You’ll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: GSK in this case.
  5. Research GlaxoSmithKline shares. The platform should provide the latest information available.
  6. Buy your GlaxoSmithKline shares. It's that simple.
Hargreaves Lansdown Hargreaves Lansdown

Best for beginners (Capital at risk)


Best for US shares (Capital at risk)

eToro eToro

Best for social trading (Capital at risk)

Interactive Investor Interactive Investor

Best for online platform (Capital at risk)

Information last updated 2020-05-31.
Open1691.6pPrevious close1671.8p
Low1656.6pChange %-0.419%
Volume1751311GMT offset0
IndustryDrug Manufacturers—GeneralCurrency symbolp
CodeGSKCountry nameUK
TypeCommon StockCountry ISOUK
NameGlaxoSmithKline plcISINGB0009252882
Currency codeGBXSectorHealthcare
Currency namePence sterlingFull-time employees99437

GlaxoSmithKline share price

Use our graph to track the performance of GSK stock price today, and over time.
eToro Free Stocks

Invest in shares with 0% commission on eToro

  • 0% commission on stocks
  • No markup, ticketing fees, management fees
  • Fractional shares available
  • Easy to use platform

Compare share dealing platforms

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Zero platform fee
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Your first 50 trades are free with Fineco, until 30/09/2020. T&Cs apply. Capital at risk.
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
Hargreaves Lansdown Fund & Share Account
Transfer out fee
Hargreaves Lansdown is the UK's biggest wealth manager, with the depth of features you'd expect from an established platform. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
Withdrawal fee & GDP to USD deposit conversion
eToro is good for social trading - letting you mirror the portfolios of other traders. Capital at risk.
Interactive Investor
From £7.99 on the Investor Service Plan
From £7.99 on the Investor Service Plan
No transfer fees or exit fees. £9.99 a month on the Investor Service Plan
Capital at risk.

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Hargreaves Lansdown stocks and shares ISA
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Interactive Investor stocks and shares ISA
£100 or £25 a month
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Legal & General stocks and shares ISA
Legal & General stocks and shares ISA
£100 or £20 a month
Legal & General is a big financial services company which offers insurance, lifetime mortgage, pensions and stocks and shares ISAs. Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Moneybox stocks and shares ISA
Moneybox stocks and shares ISA
Fixed subscripction fee of £1 per month
Moneybox offers a general investment account, Lifetime ISA and Junior ISA and lets you manage your money with an easy-to-use app. Capital at risk.
Nutmeg stocks and shares ISA
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
2,500 funds
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Interactive Investor Pension
Over 2,500 funds
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
AJ Bell Pension
Over 2,000 funds
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
Moneybox Pension
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.
Moneyfarm Pension
Moneyfarm Pension
7 funds
£1,500 (initial investment)
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Capital is at risk.

This is not a recommendation, it represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

GlaxoSmithKline stock summary

GlaxoSmithKline plc (LON: GSK) was formed following the merger of Glaxo Wellcome and SmithKline Beecham in 2000. GSK was originally listed on the London Stock Exchange (LSE: GSK) in May 1972 and is a part of the FTSE 100 Index. GlaxoSmithKline is one of the largest companies on the LSE by market capitalisation, and also has a secondary listing on the New York Stock Exchange.

Where can I buy GlaxoSmithKline shares in the UK?

You can buy and sell GlaxoSmithKline (LON: GSK) shares in the UK on the London Stock Exchange, and as part of the FTSE 100 Index. In the US, GSK shares can be traded on the New York Stock Exchange.

What affects the GlaxoSmithKline share price?

The GSK share price is influenced by a number of factors, such as the company's financial performance, outlook and operations, and the overall state of the pharmaceutical industry. The GSK share price will also be affected by wider stock market trends and investor behaviour. Like with many stocks, the GlaxoSmithKline (GSK) share price dropped in March 2020 due to the coronavirus stock market crash, but made a recovery in April. However, the price of GSK shares has been relatively volatile over its history, and recorded it's all-time high share price back in 1999.

Are GlaxoSmithKline shares a good buy now?

According to investing websites The Motley Fool and Stockopedia, GSK shares may be a good investment based on its cash flow, returns and potential demand. With the coronavirus pandemic, stocks such as GlaxoSmithKline may see an uptick in interest and demand as investors may see pharmaceutical companies as a safer bet in the current climate.

Frequently asked questions

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site